ADMA Biologics Archives

Press ESC key to close search

Ares Management Provides $135MM Refinancing Credit Facilities to ADMA Biologics

ADMA Biologics executed a definitive credit agreement with Ares Management’s credit funds for $135 million in total senior secured credit facilities, including a $72.5 million asset-backed revolving credit facility and a $62.5 million term loan.

Hayfin Capital Management Completes Credit Agreement Amendment with ADMA Biologics

ADMA Biologics, a commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, amended the terms of its existing senior credit facility with Hayfin Capital Management, which matures in March 2027.

May 3, 2023 Adam Grossman | ADMA Biologics | Hayfin Capital Management | Howard Rowe Ian Koplin

Hercules Tech Provides ADMA Biologics $5MM Tranche

ADMA Biologics, a late stage biopharmaceutical company, received a $5 million tranche from Hercules Technology Growth Capital.

December 16, 2014 ADMA Biologics | Hercules Technology Growth Capital ABF Journal

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: ADMA Biologics

Ares Management Provides $135MM Refinancing Credit Facilities to ADMA Biologics

Hayfin Capital Management Completes Credit Agreement Amendment with ADMA Biologics

Hercules Tech Provides ADMA Biologics $5MM Tranche